Supply Notification: H2-antagonists (Cimetidine, Famotidine and Nizatidine) – Update

Supply Notification: H2-antagonists (Cimetidine, Famotidine and Nizatidine) – Update

March 30, 2020

Update (30/03/2020): resupply dates now expected:

  • Famotidine 20mg tablets are out of stock until 14th April 2020 (Tilomed) May 2020 (Teva) 
  • Famotidine 40mg tablets are out of stock until April 2020 (Teva)
  • Cimetidine 200mg tablets are out of stock until 30th March 2020 (Ennogen) January 2021 (Medley Pharma)
  • Cimetidine 400mg tablets are out of stock until 30th March 2020 (Ennogen) 30th August 2020 (Medreich)
  • Cimetidine 800mg tablets are out of stock until 30th March 2020 (Ennogen)
  • Nizatidine 150mg and 300mg tablets: No confirmed resupply date (Medreich and Mylan)

Department of Health and Social Care (DHSC) has issued a medicine supply notification for H2-antagonists (Cimetidine, Famotidine and Nizatidine)

Suppliers of Cimetidine, Famotidine and Nizatidine have reported an increase in demand, which has contributed to short term shortages of Cimetidine 200mg tablets, Famotidine 20mg tablets, and Nizatidine 150mg and 300mg tablets.

  • Famotidine 20mg tablets are out of stock until the end of December 2019.
  • Cimetidine 200mg tablets are out of stock until the end of January 2020.
  • Nizatidine 150mg and 300mg tablets are out of stock until February 2020.

The DHSC Medicine Supply Team provide a monthly update on potential supply issues affecting both primary and secondary care. This update is uploaded on the Specialist Pharmacy Services (SPS) website. To register, you will need  an NHS email address. Once set up and logged in, you will be able to access it online.



Posted in:


More Latest News >

Funding for Easter opening hours

Further to NHS England and NHS Improvement’s (NHSE&I) decision that community pharmacies in England must open between 2pm and 5pm...